Expression of androgen receptor in invasive ductal breast carcinomas: a clinicopathological study from Jordan

The clinical relevance of androgen receptors (ARs) expressed in breast cancer cells and the suggested prognostic impact has been an area of active research. The prevalence rate of AR expression in breast cancer has never been reported among Jordanian patients